CLINICAL_TRIALS
trial_result
· 2025-04-04
Clinical Trial Update: Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease [Phase 1]
Summary
Phase 1 clinical trial assessing direct intracerebral injection of autologous activated adipose-derived stem cells (RB-ADSC) for mild-to-moderate Alzheimer's di…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneration Biomedical, Inc. | Conditions: Alzheimer Disease | Phase 1 | Status: RECRUITING